Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing—“Yes”
Leoni Rolfes, Sven G. Meuth
Topics & Concepts
Multiple sclerosisDosingMedicineInterval (graph theory)Intensive care medicineInternal medicineImmunologyMathematicsCombinatoricsMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSystemic Sclerosis and Related Diseases